Table 4.
Patient #1 | Patient #2 | Patient #3 | Patient #4 | Patient #5 | Patient #6 | Patient #7 | Patient #8 | Patient #9 | Patient #10 | |
---|---|---|---|---|---|---|---|---|---|---|
Death | No | No | No | No | No | No | No | No | No | No |
Hospitalization length, days | 4 | 13 | 3 | 4 | 4 | 18 | 6 | 12 | 4 | 5 |
Vascular complications | No | No | No | No | No | No | No | No | No | No |
Bleeding complications | No | No | No | No | No | No | No | Yesa | No | No |
Renal Function | ||||||||||
Baseline serum creatinine, md/dL | 2.01 | 3.10 | 2.39 | 3.16 | 2.33 | 3.2 | 1.83 | 3.3 | 3.65 | 1.49 |
Baseline creatinine clearance, mL/min | 50.19 | 18.32 | 23.72 | 41.10 | 24.62 | 17.49 | 26.9 | 18.03 | 9.91 | 38.26 |
Post imaging serum creatinine, md/dL | 2.26 | 3.01 | 2.37 | 3.08 | 2.45 | 2.93 | 1.73 | 3.25 | 3.98 | 1.56 |
Post imaging creatinine clearance, mL/min | 44.64 | 18.87 | 23.92 | 42.16 | 23.41 | 19.16 | 31.49 | 18.36 | 9.16 | 36.54 |
Post-TAVI* (at discharge) serum creatinine, mg/dL | 2.24 | 4.00 | 2.27 | 2.37 | 1.71 | 2.34 | 1.62 | 4.01 | 2.54 | 1.46 |
Post-TAVI*(at discharge) creatinine clearance, mL/min | 45.04 | 14.2 | 24.97 | 55.26 | 33.54 | 23.91 | 33.44 | 14.84 | 14.24 | 39.04 |
Need for dialysis | No | Yesb | No | No | No | No | No | No | No | No |
*TAVI = Transcatheter aortic valve implantation.
aGastrointestinal bleeding associated with Clostridium difficile infection; VARC-3 type 1 of bleeding [12].
bUltrafiltration modality due to congestive symptoms after transcatheter aortic valve implantation.